Results
Patients and cycles characteristics were equally distributed among
Supplementation and Control groups. Implantation rate (25.2% vs. 20.5%,
p<0.001) and clinical pregnancy rate (41.0% vs. 22.0%, p=0.039) were
significantly higher in the Supplementation compared to the Control
group.